Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04632030 · ClinicalTrials.gov registry record · NA
Shrinking the Size of the Tobacco Power Wall
A NA study, sponsored by RAND.
- Completed
- Registry status
- NA
- Development phase
- 275
- Enrollment target
NCT04632030: Completed NA study, sponsored by RAND.
NCT04632030 is a NA study that has completed, run by RAND. The registered enrollment target is 275 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (80% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04632030, a NA study, has completed, sponsored by RAND.
- COMPLETED
- Registry status
- NA
- Development phase
- 275 participants
- Enrollment target
Study Summary
The overall aim of this research is to experimentally evaluate the extent to which reducing the size of the tobacco power wall and the number of tobacco product units displayed influences tobacco use risk in adolescents.
Primary Outcome
A two item self-report assessment: 1) If one of your best friends offered you an unflavored cigarette would you use it? 2) If one of your best friends offered you a menthol cigarette would you use it? Responses to each item are made on a 10-point scale where 1 = definitely not; and 10 = definitely yes and responses across the two items are summed for a total scale score. Total scale scores are dichotomized: scores of 2 are coded as '0' (no risk) and any score greater than 2 is coded as '1' (at r
Interventions
- BEHAVIORAL Tobacco power wall size and tobacco products displayed
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 275 participants |
| Start Date | 2020-10-30 |
| Est. Completion | 2022-08-29 |
| Phase | NA |
What the finished NCT04632030 record still lists
NCT04632030 is an interventional study that assigns participants to a tested intervention. The registered 275 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (80% lower).
The record links to 0 conditions, and to 1 intervention - of which Tobacco power wall size and tobacco products displayed is the first listed.
NCT04632030 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04632030 about?
NCT04632030 is a clinical study titled "Shrinking the Size of the Tobacco Power Wall". The overall aim of this research is to experimentally evaluate the extent to which reducing the size of the tobacco power wall and the number of tobacco product units displayed influences tobacco use risk in adolescents.
What is the current status of trial NCT04632030?
This trial is currently completed. It is a NA study. The enrollment target is 275 participants. The study started on 2020-10-30. Estimated completion is 2022-08-29.
What interventions are being tested in trial NCT04632030?
The interventions under investigation include: Tobacco power wall size and tobacco products displayed (BEHAVIORAL).
Who is sponsoring clinical trial NCT04632030?
This trial is sponsored by RAND, which has 78 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04632030's enrollment target sits among peer trials
275 383rd of 2000 higher than 1,616 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01269190 · 275 participants · NA
Wide-Field and High Resolution In Vivo Imaging in Visualizing Lesions in Patients With Oral Neoplasia Undergoing Surgery
- NCT01900132 · 275 participants · NA
Electrical Impedance Myography: Natural History Studies inNeuromuscular Disorders and Healthy Volunteers
- NCT04104776 · 275 participants · Phase 1
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
- NCT04765150 · 275 participants
Integrating Quantitative MRI and Artificial Intelligence to Improve Prostate Cancer Classification
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI